1. Introduction {#s0005}
===============

Schizophrenia is a chronic and severe neuropsychiatric disorder that can trigger a range of positive and negative symptoms, including hallucinations, delusions, cognitive impairment, loss of motivation and impaired ability to manage emotions and relationships. The illness presents in several forms including paranoid symptoms.

Schizophrenia occurs in almost 1% of the population worldwide ([@bb0145]). There is a genetic underpinning with other factors including viral and immunological factors, brain injury and drug abuse being implicated ([@bb0170], [@bb0030], [@bb0195], [@bb0200], [@bb0185], [@bb0140], [@bb0155], [@bb0095], [@bb0050]; [@bb0190], [@bb0120], [@bb0125], [@bb0090]). However, clinical and genetic heterogeneity and overlapping with other neurodevelopmental disorders complicate our understanding of the etiology of schizophrenia.

Both common and rare genetic variants have been associated with schizophrenia ([@bb0075]). The major histocompatibility complex (MHC), an immune response gene locus on chromosome 6 is the most extensively associated locus for schizophrenia in GWAS ([@bb0170], [@bb0200]). It has been postulated that MHC function may be affected by viral infection of the expectant mother in turn perturbing MHC\'s role in synaptogenesis in the unborn child ([@bb0140]). The largest GWAS to date identified significant associations spanning 108 conservatively defined loci --- enriched for synapse associated genes ([@bb0200]). Rare variant association studies are also enriched for synapse-associated genes including *DISC1*, *ARC*, several calcium channel genes and the *NMDAR* ([@bb0205], [@bb0130], [@bb0210], [@bb0175], [@bb0215], [@bb0065]).

To better understand the etiology of schizophrenia in a population of Emirati Arabs, we applied a candidate gene association approach to schizophrenia for previously implicated genes *DISC1*, *PICK1* and *NRG3* as well as *PDLIM5*, a gene upregulated in the brain of schizophrenia patients.

2. Patients and methods {#s0025}
=======================

2.1. Patient selection {#s0030}
----------------------

Participants over the age of 18 were recruited from outpatient attendees at Al Ain Hospital, in Al Ain city, United Arab Emirates in accordance with the Al Ain Medical District Human Research Ethics Committee. Diagnosis was based on the Diagnostic and Statistical Manual of Mental Disorders 4th Edition Text Revision (DSM-IV-TR) clinical criteria ([@bb0010]) by way of a semi-structured interview, comprehensive medical and psychiatric history taking, mental state examination and collateral information from family members. Participants were excluded from the study if they had comorbid alcohol or drug dependence, depressive disorder, or bipolar affective disorder. Patients consisted of 71 males (58.7%) and 50 females (41.3%) with diagnosis of schizophrenia, aged 18--82 year old with a mean age of 37.1 (+/− 12.6) years. Eighty nine (73.6%) were diagnosed as paranoid schizophrenia (65.2% men and 34.8% women), ten (8.3%) with disorganized type, two (1.7%) with residual, one (0.8%) with schizoaffective, four (3.3%) undifferentiated type, and 15 (12.4%) as not otherwise specified. Paranoid schizophrenia was significantly more frequent among men (58, 65.2%) compared to women (31, 34.8%) (χ^2^ = 12.18, df = 5, P = 0.03).

Fifty one patients (42.5%) were married, 58 (48.4%) were single, one (0.8%) was separated, seven (5.8%) were divorced and three of the females (2.5%) were widowers. There was no statistically significant difference between genders in marital status. Seventy two (59.5%) patients were unemployed and 26 (21.5%) were housewives. Sixteen (13.2%) were employed in clerical positions, four (3.3%) were retired, 2 (1.7%) were students and one (0.8%) was working in the police. In this cohort the correlation between unemployment and schizophrenia was statistically significant (χ^2^ = 43.45, df = 6, P = 0.001).

2.2. Genotyping {#s0035}
---------------

121 patients with schizophrenia (SCZ) and 170 controls were genotyped using quality controlled primers ([Table 1](#t0005){ref-type="table"}). PCR amplicons spanning SNPs from the respective genes were sequenced and analyzed using ClustalW2 against gene reference sequences [NM_001039583.1](ncbi-n:NM_001039583.1){#ir0040} for *PICK1*, [NM_006457.4](ncbi-n:NM_006457.4){#ir0045} for *PDLIM5*, [NM_001010848.3](ncbi-n:NM_001010848.3){#ir0050} for *NRG3* and [NM_001012957.1](ncbi-n:NM_001012957.1){#ir0055} for *DISC1*.

3. Quality control and statistical analysis {#s0040}
===========================================

Quality control (QC) was performed with PLINK software ([@bb0165]). The chi square test was used to test for associations between SNVs and phenotypes. A logistic regression analysis was done with patients/control as dependent factor and SNVs as predictor factors.

3.1. Allelic association {#s0045}
------------------------

Allelic association analysis was performed with PLINK software (5% of significance level). QQ plots were performed with the WGA-Viewer software ([@bb0080], [@bb0085]), and Manhattan plot and linkage disequilibrium (LD) evaluation were performed with Haploview software ([@bb0015]). Power analysis was performed with Quanto (<http://hydra.usc.edu/gxe/>), showing that for SNPs with MAF of P0.05, given our sample size, we had over 80% power to detect associations with odds ratio (OR) of P2.0; however, it showed much lower power to detect associations with smaller ORs (1.2).

4. Results {#s0010}
==========

We evaluated a total of 295 Emirati individuals (121 with schizophrenia and 174 normal controls) for associations with variants in four genes (*DISC1*, *PICK1*, *NRG3* and *PDLIM5*) previously were shown to be associated with schizophrenia. Using the chi square test (95% confidence interval) none of the sequence variants were found to be significantly associated with schizophrenia in this Arab cohort. [Table 2](#t0010){ref-type="table"} shows comparison of patients and controls in single nucleotide variations (SNVs) for the four different genes tested.

Furthermore, the patients\' group was divided into paranoid schizophrenia and non-paranoid schizophrenia. Chi square test was used to test for an association between SNVs and paranoid schizophrenia. The three *PDLIM5* SNVs; rs14082 (χ^2^ = 7.807, df = 2, P = 0.02), rs12641023 (χ^2^ = 7.56, df = 2, P = 0.023), and rs11339365 (χ^2^ = 14.53, df = 2, P = 0.001) were found significantly more frequent in paranoid schizophrenia group as well as *PICK1* SNV rs880669 (χ^2^ = 6.317, DF = 2, P = 0.042) ([Table 3](#t0015){ref-type="table"}).

5. Subtypes of schizophrenia and association with genes {#s0050}
=======================================================

The chi square test was used to test for associations between SNVs of *PDLIM5* (rs14082, rs11339365, and rs10590) and subtypes of schizophrenia. There was significant association with rs14082 and rs11339365 but not with rs10590 ([Table 4](#t0020){ref-type="table"}, [Table 5](#t0025){ref-type="table"}, [Table 6](#t0030){ref-type="table"}).

A logistic regression analysis was done with patients/control as a dependent factor and SNVs as predictor factors (for *DISC1*, *PICK1*, *NRG3* and *PDLIM5*). The results showed that of these SNVs only rs11339365 from *PDLIM5* was a significant predictor of schizophrenia (Wald = 5.997, P = 0.014, CI = 1.080--1.995).

A further logistic regression used paranoid/non-paranoid schizophrenia as a dependent factor and SNVs as predictor factors (for *DISC1*, *PICK1*, *NRG3* and *PDLIM5*). Again rs11339365 from *PDLIM5* was found to be a significant predictor of paranoid schizophrenia (Wald = 10.806, P = 0.002, CI = 1.885--17.508).

6. Discussion {#s0015}
=============

The current study aimed to test the association of schizophrenia in Emirati Arabs with genetic variants in four schizophrenia candidate genes namely *DISC1*, *PICK1*, *NRG3* and *PDLIM5*. No such association was established in this relatively small cohort of patients. However, *PDLIM5* was found to be a significant secondary predictor of the paranoid subtype of schizophrenia in this Emirati Arab cohort.

PDLIM5 is localized to the postsynaptic density where it has an important role in limiting the size of dendritic spines --- the small synaptic protrusions that serve as the primary sites of excitatory synaptic transmission in the CNS ([@bb0100], [@bb0035]). Spine morphology is thought to play important roles in synaptic development and plasticity ([@bb0040]) with larger spines possessing greater synaptic strength and stability and morphological derangements in spines correlating with several neurological disorders ([@bb0150], [@bb0180]). *PDLIM5* has been associated with schizophrenia, bipolar disorder and major depression and its expression is upregulated in the brain of schizophrenia patients suggesting a possible pathogenic role in the etiology of schizophrenia ([@bb0115], [@bb0110]). The finding here of *PDLIM5* as a potential marker of schizophrenia subtype expands the role of synaptogenesis in neuropsychiatric disorders more generally ([@bb0055], [@bb0060]) thus beckoning further investigation of *PDLIM5* variant correlation in a larger study and their relationship to brain expression levels in patients post-mortem.

7. Conclusions {#s0020}
==============

Our findings suggest that *PDLIM5* is a possible secondary determinate/marker for the paranoid schizophrenia subtype in Emirati Arabs. Consanguinity is an established risk factor for schizophrenia ([@bb0070], [@bb0135], [@bb0045], [@bb0020]) and a study by [@bb0005] demonstrated the utility of family-based studies for the identification of schizophrenia susceptibility genes. Therefore, our next step will be to carry out deeper genetic analysis involving whole-genome SNV genotyping and whole-exome sequencing to identify variants that are relevant to the development of schizophrenia in Emiratis.

We thank the subjects and volunteers for taking part in this study. The project was funded by United Arab Emirates University (grant no. 01-08-8-12/08).

###### 

The analyzed single nucleotide variations (SNVs), their corresponding genes and primers.

  Gene                                                SNV                                           HGVS names                                                  Primers
  --------------------------------------------------- --------------------------------------------- ----------------------------------------------------------- -------------------------------------------------
  *PDLIM5*                                            rs7690296                                     NM_001011513.3:c.814A \> G NP_001011513.3:p.T272A           ggcaacaagagcgaaactct; cattacacatacttccaaatgcaaa
                                                      rs14082                                       NM_001011513.3:c.\*1006A \> G NM_001011513.3:c.\*1048delT   tttttgccttacagtggatca; tttaagagccggagtcttgc
                                                      rs11339365                                                                                                
                                                      rs10590                                       NM_001011513.3:c.\*1061T\>C NM_001011513.3:c.292-212C\>T    gctgctaacctgattgtgtttg; tggagactggtcagcactaaga
                                                      rs2452600                                                                                                 
                                                      rs12641023                                    NM_001011513.3:c.956 + 412G\>A                              aatgaaaggtaatacggaggtct; tcacgaagtgcaacaaggtc
  *PICK1*                                             rs2076369                                     NM_001039583.1:c.283-59G\>T                                 tctttgcctcagcctcct; ggacacccgtaactgctctg
                                                      rs880669                                      NM_001039583.1:c.283-176C\>T                                
  *NRG3*                                              rs2295933                                     NM_001010848.3:c.1986C\>T                                   
  NP_001010848.2:p.S662 = NM_001010848.3:c.1829T\>G   aatgccagggatttctgaag; tcacttggtcaatgcagagtc                                                               
                                                      rs959317                                                                                                  
  NP_001010848.2:p.V610G                              ctgccatcagcagagttgag; ccagtgagggatccagagaa                                                                
  *DISC1*                                             rs3738401                                     NM_001012957.1:c.791G\>A NP_001012975.1:p.R264Q             

###### 

Patient--control comparison of the studied variations in *PICK1*, *PDLIM5*, *NRG3* and *DISC1* genes.

  SNV                  Subjects (n = 295)   Genotype count (%)   χ^2^        P             
  -------------------- -------------------- -------------------- ----------- ----- ------- -------
  PICK1 rs880669                            C/C                  C/T         T/T   1.725   .422
  Patient (113)        70 (61.9)            39 (34.5)            4 (3.5)                   
  Control (172)        107 (62.2)           53 (30.8)            12 (7.0)                  
  PICK1 rs2076369                           G/G                  G/T         G/T   4.476   .107
  Patient (114)        47 (37.6)            59 (45.4)            8 (25.8)                  
  Control (172)        78 (62.4)            71 (54.6)            23 (74.2)                 
  *PDLIM5*rs7690296                         A/A                  A/G         G/G   .390    .823
  Patient (181)        30 (39.0)            61 (42.4)            27 (38.6)                 
  Control (173)        47 (61.0)            83 (57.6)            43 (61.4)                 
  PDLIM5 rs7690464                          C/C                  C/T         T/T   1.471   .225
  Patient (118)        117 (40.3)           1 (100.0)            0 (0.0)                   
  Control (173)        173 (59.7)           0 (0.0)              0 (0.0)                   
  PDLIM5 rs14082                            A/A                  A/G         G/G   .000    1.000
  Patient (112)        24 (40.0)            58 (40.0)            30 (40.0)                 
  Control (168)        36 (36.0)            87 (60.0)            45 (60.0)                 
  *PDLIM5*rs11339365                        T/T                  T/−         −/−   2.771   .250
  Patient (116)        30 (35.7)            62 (45.9)            24 (36.9)                 
  Control (168)        54 (64.3)            73 (54.1)            41 (63.1)                 
  *PDLIM5*rs10590                           T/T                  T/C         C/C   1.277   .528
  Patient (116)        49 (37.4)            55 (44.4)            12 (41.4)                 
  Control (168)        82 (62.6)            69 (55.6)            17 (58.6)                 
  *PDLIM5*rs2452600                         C/C                  C/T         T/T   1.596   .450
  Patient (121)        76 (40.0)            38 (42.2)            7 (38.3)                  
  Control (171)        114 (60.0)           52 (57.8)            5 (41.7)                  
  *PDLIM5*rs12641023                        G/G                  G/A         A/A   .217    .897
  Patient (121)        32 (42.1)            58 (42.3)            31 (39.2)                 
  Control (171)        44 (57.9)            79 (57.7)            48 (60.8)                 
  *NRG3*rs2295933                           C/C                  C/T         T/T   .273    .873
  Patient (117)        40 (40.0)            60 (42.0)            17 (37.8)                 
  Control (171)        60 (60.0)            83 (58.0)            28 (16.2)                 
  *NRG3*rs959317                            T/T                  T/G         G/G   1.973   .373
  Patient (117)        110 (39.9)           3 (50.0)             4 (66.7)                  
  Control (171)        166 (60.1)           3 (50.0)             2 (33.3)                  
  *DISC1* rs3738401                         G/G                  G/A         A/A   2.606   .272
  Patient (120)        79 (44.6)            39 (36.4)            2 (66.7)                  
  Control (167)        98 (55.4)            68 (63.6)            1 (33.3)                  

SNV = Single nucleotide variation.

###### 

paranoid/non-paranoid schizophrenia comparison of studied variations in *PICK1*, *PDLIM5*, *NRG3* and *DISC1* genes.

  SNV                  Subjects    Genotype count (%)   χ^2^        P             
  -------------------- ----------- -------------------- ----------- ----- ------- ------
  *PICK1rs880669*                  CC                   C/T         T/T   6.32    .04
  Paranoid             56 (50.0)   23 (20.5)            4 (3.6)                   
  Non-paranoid         14 (12.5)   15 (13.4)            0 (0.0)                   
  *PICK1 rs2076369*                G/G                  G/T         T/T   1.76    .42
  Paranoid             33 (29.2)   46 (40.7)            5 (4.4)                   
  Non-paranoid         14 (12.4)   12 (10.6)            3 (2.7)                   
  *PDLIM5rs*7690296                A/A                  A/G         G/G   5.48    .06
  Paranoid             26 (22.)    44 (37.6)            16 (13.7)                 
  Non-paranoid         4 (3.4)     16 (13.7)            11 (9.4)                  
  PDLIM5 *rs*7690464               C/C                  C/T         T/T   .364    .55
  Paranoid             85 (72.6)   1 (0.9)              0                         
  Non-paranoid         31 (26.5)   0 (0.0)              0                         
  PDLIM5 *rs*14082                 A/A                  A/G         G/G   7.81    .02
  Paranoid             14 (12.6)   45 (40.5)            27 (24.3)                 
  Non-paranoid         10 (9.0)    12 (10.8)            3 (2.7)                   
  *PDLIM5*rs11339365               T/T                  T/−         −/−   14.53   .001
  Paranoid             52 (45.2)   15 (13.0)            20 (17.4)                 
  Non-paranoid         9 (7.8)     15 (13.0)            4 (3.5)                   
  *PDLIM5*rs10590                  T/T                  T/C         C/C   5.51    .06
  Paranoid             32 (27.8)   46 (40.0)            9 (7.8)                   
  Non-paranoid         17 (14.8)   8 (7.0)              3 (2.6)                   
  *PDLIM5*rs2452600                C/C                  C/T         T/T   1.21    .55
  Paranoid             54 (45.0)   29 (24.2)            6 (5.0)                   
  Non-paranoid         22 (18.3)   8 (6.7)              1 (0.8)                   
  *PDLIM5*rs12641023               G/G                  G/A         A/A   7.57    .02
  Paranoid             26 (21.7)   45 (37.5)            18 (15.0)                 
  Non-paranoid         5 (4.2)     12 (10.0)            14 (11.7)                 
  *NRG3*rs2295933                  C/C                  C/T         T/T   .59     .75
  Paranoid             2 (1.7)     26 (21.8)            60 (50.4)                 
  Non-paranoid         0 (0.0)     13 (10.9)            18 (15.1)                 
  *NRG3*rs959317                   T/T                  T/G         G/G   2.34    .31
  Paranoid             82 (70.7)   3 (2.6)              2 (1.7)                   
  Non-paranoid         27 (23.3)   0 (0.0)              2 (1.7)                   
  *DISC1* rs3738401                G/G                  G/A         A/A   2.14    .34
  Paranoid             60 (50.4)   26 (21.8)            2 (1.7)                   
  Non-paranoid         18 (15.1)   13 (10.9)            0 (0.0)                   

SNV = Single nucleotide variation.

###### 

Different types of schizophrenia among *PDLIM5 rs14082* genotypes.

  Type of schizophrenia     Patients (n = 121) (%)   Genotype count (%)   χ^2^        P                   
  ------------------------- ------------------------ -------------------- ----------- ----------- ------- ------
  Paranoid                  89 (73.6)                14 (11.6)            45 (37.2)   27 (22.3)   25.42   .045
  Disorganized              10 (8.3)                 4 (3.4)              3 (2.5)     1 (0.8)             
  Undifferentiated          4 (3.3)                  1 (0.8)              1 (0.8)     0 (0.0)             
  Residual                  2 (1.6)                  1 (0.8)              1 (0.8)     0 (0.0)             
  Schizoaffective           1 (0.8)                  0 (0.0)              1 (0.8)     0 (0.0)             
  Not otherwise specified   15 (12.4)                4 (3.4)              7 (5.8)     2 (1.7)             

###### 

Different types of schizophrenia among *PDLIM5*rs11339365 genotypes.

  Type of schizophrenia     Patients (n = 121) (%)   Genotype count (%)   χ^2^        P                   
  ------------------------- ------------------------ -------------------- ----------- ----------- ------- ------
  Paranoid                  89 (73.6)                15 (12.4)            52 (43.0)   20 (16.5)   28.83   .017
  Disorganized              10 (8.3)                 6 (5.0)              2 (1.7)     2 (1.7)             
  Undifferentiated          4 (3.3)                  3 (2.5)              0 (0.0)     0 (0.0)             
  Residual                  2 (1.6)                  1 (0.8)              1 (0.8)     0 (0.0)             
  Schizoaffective           1 (0.8)                  0 (0.0)              1 (0.8)     0 (0.0)             
  Not otherwise specified   15 (12.4)                5 (4.1)              6 (5.0)     2 (1.7)             

###### 

Different types of schizophrenia among *PDLIM5 rs10590* genotypes.

  Type of schizophrenia     Subjects (n = 295) (%)   Genotype count (%)   χ^2^        P                  
  ------------------------- ------------------------ -------------------- ----------- ---------- ------- ------
  Paranoid                  89 (30.2)                32 (10.8)            46 (15.6)   9 (3.1)    22.54   .209
  Disorganized              10 (3.4)                 6 (2.0)              2 (10.7)    2 (0.7)            
  Undifferentiated          4 (1.4)                  2 (0.7)              0 (0.0)     1 (0.3)            
  Residual                  2 (0.7)                  1 (0.3)              1 (0.3)     0 (0.0)            
  Schizoaffective           1 (0.3)                  0 (0.0)              1 (0.3)     0 (0.0)            
  Not otherwise specified   15 (5.1)                 8 (2.7)              5 (1.7)     0 (0.0)            
  Control                   174 (59.0)               82 (27.8)            69 (23.4)   17 (5.8)           
